Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2024-05-23
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adult Oral Ibuprofen Study for ED Pain Patients
NCT03441269
Analgesic Effect of Paracetamol, Paracetamol + Codeine, Ibuprofen and Their Combination
NCT00921700
Assessing the Efficacy of IV Ibuprofen for Treatment of Pain in Orthopedic Trauma Patients
NCT02152163
Assessment of the Analgesic Effects of PF-06273340 in Healthy Volunteers Using Evoked Pain Endpoints
NCT02260947
Analgesic Effect of Ibuprofen, Paracetamol (Acetaminophen), and Paracetamol (Acetaminophen) Plus Codeine on Acute Pain
NCT00699114
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Open-label Placebo
Treatment with open-label placebo pills 3x/day
Placebo (open-label)
P-Tabletten weiss 10mm (Lichtenstein, Zentiva) pills 3x/day
Treatment as usual
Treatment as usual defined as Ibuprofen 3x/day
Ibuprofen 400 mg
Ibuprofen pills 3x/day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo (open-label)
P-Tabletten weiss 10mm (Lichtenstein, Zentiva) pills 3x/day
Ibuprofen 400 mg
Ibuprofen pills 3x/day
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to understand the study and its outcome measures
* Signed informed consent
* 18 years or older
* Sufficient German language skills
Exclusion Criteria
* Treatment with pain medication for \> 7 days prior to ED visit
* Known allergy or intolerance to ibuprofen
* Known hereditary galactose-intolerance, lactase deficiency or glucosegalactose malabsorption
* Participation in another clinical trial with medicinal products
* Need for hospitalization
* Known pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Roland Bingisser, Principal Investigator, Head of Emergency Department, University Hospital Basel
UNKNOWN
Jens Gaab, Co-investigator, Head of Division University of Basel, Faculty of Psychology
UNKNOWN
Bojana Degen, Co-investigator, University of Basel, Faculty of Psychology
UNKNOWN
Anna Szczesna, Co-investigator, University Hospital Basel, Emergency Department
UNKNOWN
Christian H Nickel, Co-investigator, Deputy Head of Emergency Department, University Hospital Basel
UNKNOWN
Bruno Minotti
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bruno Minotti
Sponsor Investigator, University Hospital Basel, Emergency Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bruno Minotti, MD
Role: STUDY_CHAIR
Emergency Department, University Hospital Basel, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Basel
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Degen B, Szczesna A, Nickel CH, Bingisser R, Gaab J, Minotti B. Open-label placebo for non-specific pain in the emergency department (OLP EM): study protocol for a mixed-method randomised control feasibility study in Switzerland. BMJ Open. 2025 Mar 25;15(3):e090508. doi: 10.1136/bmjopen-2024-090508.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-00089; am24Bingisser
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.